Pluristem Therapeutics, Inc. Competitors

PSTI 
$3.06
*  
0.06
  negative  
2%
Get PSTI Alerts
*Delayed - data as of May 21, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Pluristem Therapeutics, Inc.
CompanyName
Symbol: Market
LastSale NetChange Volume Today's High/ Low 52 Weeks High/ Low P/ERatio Market Cap
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 32.40 0.24   384,022 $ 32.46
$ 31.74
$ 40.87
$ 21.26
9.03 1,305,072,000
Amgen Inc.
AMGN: NASDAQ-GS
$ 104.24 2.06   3,490,307 $ 104.68
$ 102.45
$ 114.95
$ 67.61
17.64 78,016,343,200
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 17.53 0.91   3,400,540 $ 17.58
$ 16.68
$ 25.40
$ 15.13
NE 3,219,962,990
BioCryst Pharmaceuticals, Inc.
BCRX: NASDAQ-GS
$ 1.70 -0.01   804,933 $ 1.72
$ 1.66
$ 4.95
$ 1.08
NE 86,496,000
Biogen Idec Inc.
BIIB: NASDAQ-GS
$ 231.33 6.15   1,364,463 $ 234.20
$ 226
$ 234.46
$ 126.39
36.72 54,666,054,960
Biota Pharmaceuticals, Inc.
BOTA: NASDAQ-GS
$ 3.72 unch 14,835 $ 3.799
$ 3.72
$ 4.71
$ 3.52
NE 105,469,440
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 26.50 0.17   18,785 $ 26.59
$ 26.34
$ 31.15
$ 7.07
15.59 704,078,500
Enzon Pharmaceuticals, Inc.
ENZN: NASDAQ-GS
$ 3.14 0.01   86,296 $ 3.18
$ 3.11
$ 7.47
$ 2.9401
NE 139,472,520
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 39.52 0.73   120,570 $ 39.53
$ 38.60
$ 58
$ 34.01
NE 1,051,903,840
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 56.47 0.73   10,089,914 $ 56.85
$ 55.76
$ 57.10
$ 24.12
31.64 85,969,532,710
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 7.59 0.02   1,412,140 $ 7.92
$ 7.42
$ 9.92
$ 3.86
NE 855,430,950
Life Technologies Corporation
LIFE: NASDAQ-GS
$ 73.68 0.11   2,179,399 $ 73.695
$ 73.52
$ 73.85
$ 39.73
31.22 12,554,114,160
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 13.08 0.21   408,096 $ 13.10
$ 12.77
$ 17.09
$ 10.05
NE 676,837,680
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 12.06 0.05   430,513 $ 12.12
$ 11.71
$ 12.85
$ 6.25
NE 802,098,540
Novavax, Inc.
NVAX: NASDAQ-GS
$ 1.96 -0.02   710,234 $ 2.02
$ 1.95
$ 2.77
$ 1.14
NE 289,964,360
ONYX Pharmaceuticals, Inc.
ONXX: NASDAQ-GS
$ 92.91 -1.43   1,329,967 $ 95.50
$ 92.71
$ 101.569
$ 41.26
NE 6,690,077,460
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 8.37 0.16   1,941,739 $ 8.37
$ 8.22
$ 8.43
$ 6.18
5.44 1,171,239,210
Qiagen N.V.
QGEN: NASDAQ-GS
$ 18.58 0.07   607,017 $ 18.72
$ 18.53
$ 22.20
$ 15.66
37.16 4,393,928,460
Repligen Corporation
RGEN: NASDAQ-GS
$ 8.61 -0.09   262,062 $ 8.77
$ 8.53
$ 9.65
$ 3.72
17.94 267,874,320
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 35.73 -0.02   450,242 $ 36.20
$ 35.50
$ 39
$ 19.03
NE 4,303,249,740
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 7.84 -0.02   682,203 $ 7.93
$ 7.62
$ 11.24
$ 4.04
NE 418,287,520
Techne Corporation
TECH: NASDAQ-GS
$ 68 0.22   120,119 $ 68.53
$ 67.52
$ 76.02
$ 62.55
22.44 2,505,256,000
Vical Incorporated
VICL: NASDAQ-GS
$ 3.63 0.02   395,272 $ 3.70
$ 3.60
$ 4.74
$ 2.61
NE 313,080,240
Biosante Pharmaceuticals, Inc.
BPAX: NASDAQ-GM
$ 1.15 unch 187,390 $ 1.15
$ 1.13
$ 3.6549
$ 1.01
NE 28,085,300
Curis, Inc.
CRIS: NASDAQ-GM
$ 3.88 -0.03   565,473 $ 3.97
$ 3.78
$ 5.51
$ 2.66
NE 310,400,000